Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes

被引:101
作者
Konishi, E
Yamaoka, M
Khin-Sane-Win
Kurane, I
Mason, PW
机构
[1] Kobe Univ, Sch Med, Dept Hlth Sci, Suma Ku, Kobe, Hyogo 65401, Japan
[2] Kobe Univ, Sch Med, Dept Med Zool, Kobe, Hyogo 650, Japan
[3] Kinki Univ, Sch Med, Dept Microbiol, Osaka 589, Japan
[4] USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA
关键词
D O I
10.1128/JVI.72.6.4925-4930.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A DNA vaccine plasmid containing the Japanese encephalitis (JE) virus premembrane (prM) and envelope (E) genes (designated pcDNA3JEME) was evaluated for immunogenicity and protective efficacy in mice. Two immunizations of 4-week-old female ICR mice with pcDNA3JEME by intramuscular or intradermal injections at a dose of 10 or 100 mu g per mouse elicited neutralizing (NEUT) antibodies at titers of 1:10 to 1:20 (90% plaque reduction), and all immunized mice survived a challenge with 10,000 50% lethal doses of the P3 strain of JE virus. A single immunization with 100 mu g of pcDNA3JEME did not elicit detectable NEUT antibodies but induced protective immunity. Spleen cells obtained from BALB/c mice immunized once with 10 or 100 mu g of pcDNA3JEME contained JE virus-specific memory cytotoxic T lymphocytes (CTLs). BALB/c mice maintained detectable levels of memory B cells and CTLs for at least 6 months after one immunization with pcDNA3JEME at a dose of 100 mu g. The CTLs induced in BALB/c mice immunized twice with 100 mu g of pcDNA3JEME were CD8 positive and recognized mainly the envelope protein. These results indicate that pcDNA3JEME has the ability to induce a protective immune response which includes JE virus-specific antibodies and CTLs.
引用
收藏
页码:4925 / 4930
页数:6
相关论文
共 36 条
  • [1] SYNTHESIS AND SECRETION OF RECOMBINANT TICK-BORNE ENCEPHALITIS-VIRUS PROTEIN-E IN SOLUBLE AND PARTICULATE FORM
    ALLISON, SL
    STADLER, K
    MANDL, CW
    KUNZ, C
    HEINZ, FX
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (09) : 5816 - 5820
  • [2] SAFETY OF AND IMMUNOLOGICAL RESPONSE TO A RECOMBINANT VACCINIA VIRUS-VACCINE EXPRESSING HIV ENVELOPE GLYCOPROTEIN
    COONEY, EL
    COLLIER, AC
    GREENBERG, PD
    COOMBS, RW
    ZARLING, J
    ARDITTI, DE
    HOFFMAN, MC
    HU, SL
    COREY, L
    [J]. LANCET, 1991, 337 (8741) : 567 - 572
  • [3] IMMUNIZATION WITH DNA
    DONNELLY, JJ
    ULMER, JB
    LIU, MA
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 176 (02) : 145 - 152
  • [4] RECOMBINANT VACCINIA VIRUSES CO-EXPRESSING DENGUE-1 GLYCOPROTEINS PRM AND E-INDUCE NEUTRALIZING ANTIBODIES IN MICE
    FONSECA, BAL
    PINCUS, S
    SHOPE, RE
    PAOLETTI, E
    MASON, PW
    [J]. VACCINE, 1994, 12 (03) : 279 - 285
  • [5] Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4(+) cytotoxic T-Lymphocyte clones
    Gagnon, SJ
    Zeng, WL
    Kurane, I
    Ennis, FA
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 141 - 147
  • [6] Germain Ronald N., 1993, P629
  • [7] SYNERGISTIC INTERACTIONS OF ANTI-NS1 MONOCLONAL-ANTIBODIES PROTECT PASSIVELY IMMUNIZED MICE FROM LETHAL CHALLENGE WITH DENGUE-2 VIRUS
    HENCHAL, EA
    HENCHAL, LS
    SCHLESINGER, JJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 1988, 69 : 2101 - 2107
  • [8] JOHNSON MP, 1988, VACCINES, V88, P189
  • [9] Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses
    Kagi, D
    Hengartner, H
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) : 472 - 477
  • [10] MONOCLONAL-ANTIBODIES FOR DENGUE VIRUS PRM GLYCOPROTEIN PROTECT MICE AGAINST LETHAL DENGUE INFECTION
    KAUFMAN, BM
    SUMMERS, PL
    DUBOIS, DR
    COHEN, WH
    GENTRY, MK
    TIMCHAK, RL
    BURKE, DS
    ECKELS, KH
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 41 (05) : 576 - 580